Article
Overview of Roles of Novel Components in the Regulation of DNA Damage Repair in BRCA1-deficient Cancers: An Update
2025-02-03
Abstract excerpt
Cancers that are arising from germline mutations of the breast cancer associated gene 1 (BRCA1), which is a crucial player of homologous recombination (HR) DNA repair, are vulnerable to DNA damaging agents such as platinum and PARP inhibitors (PAR-Pi). Increasing evidence suggests that BRCA1 is an essential driver of all phases of the cell cycle, thereby maintaining orderly steps during cell cycle progression. Spe...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fac8b9b9-1ef0-5280-abf1-bf1091d20548
- DOI
- 10.20944/preprints202502.0062.v1
